Dr. Jonathan Spages Expands Diabetes Reversal Practice Across New States, Adds Clinical Team to Meet Growing Demand

February 9, 2026 4:00 AM

Dr. Jonathan Spages, nationally recognized functional medicine practitioner and leading authority on Type 2 diabetes reversal, announced today the expansion of his practice into additional states along with the hiring of new clinical staff to serve the growing number of patients seeking a root-cause approach to improving blood sugar health.For over 20 years, Dr. Spages has helped more than 10,000 individuals with Type 2 diabetes reduce or...

Read more

Weed.de Warns: Proposed Cannabis Amendment Threatens Patient Access to Care

February 9, 2026 3:00 AM

The digital health platform Weed.de is issuing a stark warning regarding the consequences of a new cannabis amendment proposed by Federal Minister of Health Nina Warken (CDU). The draft law introduces drastic restrictions that experts predict would lead to a massive shortfall in patient care. Key Provisions of the BillThe draft law outlines three central restrictions:A ban on initial telemedical prescriptions for cannabis flower.A requirement...

Read more

UK-Based Vesalic Limited Emerges from Stealth with Landmark Discovery of Potential Non-CNS Driver of Motor Neuron Diseases, including ALS, and Breakthrough Therapeutic and Diagnostic Opportunities

February 9, 2026 12:00 AM

Vesalic Limited, an early-stage neurodegenerative disease-focused biotech company, today emerged from stealth with the landmark discovery of a systemic process - largely external to the brain and central nervous system (CNS) - that is suspected to be a major contributor to motor neuron diseases (MND), including amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases (NDDs). This discovery could potentially transform...

Read more

Agape ATP Corporation Announces 1-For-50 Reverse Stock Split

February 6, 2026 11:00 AM

Agape ATP Corporation (NASDAQ:ATPC) ("ATPC" or "the Company") announced that it intends to implement a 1-for-50 reverse stock split of its issued and outstanding common stock.The reverse stock split was approved by the Company's shareholders at the Annual Meeting held on 30 January 2026, following the approval of an amendment to the Company's Articles of Incorporation that authorises the Board of Directors to effect one or more reverse stock...

Read more

Canadian Home Healthcare Calls for Greater Awareness of 24/7 Home Care Needs

February 6, 2026 10:23 AM

Canadian Home Healthcare is raising awareness of the critical importance of continuous, around-the-clock home healthcare for individuals who rely on respiratory support, such as CPAP therapy and home oxygen. Drawing on more than 20 years of experience delivering care across Ontario, the organisation is urging clients, caregivers, and families to take a more active role in understanding and maintaining their home-based treatment.Home healthcare...

Read more

Ameerex Confirms Major Heavy Rare Earth Mineralization in Brazil JV Across the Goiás-Araxá-Catalão Belt - Brazil Ranking Second to China by Estimated REE Resources

February 6, 2026 10:15 AM

ATLANTA, GA and DOHA, QATAR / ACCESS Newswire / February 6, 2026 / Ameerex Corporation (OTC:HIRU) ("Ameerex" or the "Company ) today confirmed major heavy rare earth element (HREE) mineralization within its Brazil joint venture with Patagonia Lithium Ltd (ASX: PL3), materially expanding the scope of a partnership previously centered on lithium and positioning the project within a globally significant critical minerals belt. There are 11 targets...

Read more

Medical Care Technologies Inc. (OTC PINK:MDCE) is Building an AI Wellness Ecosystem with New Lifestyle Application Category

February 6, 2026 9:30 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) today announced continued progress in building a long-term, AI-powered wellness ecosystem through the expansion of its new Lifestyle and Wellness Application category. This strategic initiative represents an important evolution of the Company's platform as it scales beyond traditional medical applications into broader consumer health and wellness markets.Leveraging its patent-pending AI imaging and...

Read more

Rural Health Transformation Funding Raises the Stakes for Rural Hospital Cash Flow as Revenue Cycle Outsourcing Demand Accelerates

February 6, 2026 8:30 AM

As first-year awards under the federal Rural Health Transformation Program begin rolling out in 2026, rural hospitals are sharpening financial priorities around liquidity, cash predictability, and reimbursement yield protection.Black Book today released early findings from its ongoing 2026 Rural Revenue Cycle and Health Information Technology Survey, based on responses from RCM and business office leaders at rural U.S. hospitals, fielded ahead...

Read more

Invitation to the Presentation of Cantargia's Annual Results for 2025

February 6, 2026 5:20 AM

Cantargia AB (publ) (Nasdaq Stockholm:CANTA) will publish the company's annual results report for 2025 on Friday, February 20, 2026, at 07:00 a.m. CET.In conjunction to the report, investors, analysts, and media are invited to an audiocast with teleconference (in English) on February 20, at 3:00 p.m. CET, where Cantargia's CEO Hilde Steineger, and CFO Patrik Renblad, will present Cantargia and comment on the report, followed by a Q&A-session.If...

Read more

InfiniWell Innovates with BPC-Lx(TM) Pro, Introducing Its Latest Oral Spray Delivery Technology

February 6, 2026 3:00 AM

InfiniWell, a science-driven wellness company focused on advanced formulation and delivery systems, has launched BPC-Lx™ Pro, its latest oral spray designed to support joint health, digestive balance, and overall body resilience. This innovation marks a strategic expansion of InfiniWell's oral delivery platform, offering consumers a convenient and efficient alternative to traditional supplement formats.BPC-Lx™ Pro utilizes InfiniWell's...

Read more

Medical Care Technologies Inc. (OTC Pink:MDCE) Signals Long-Term Potential to Redefine Consumer Dermatology Standards Through AI

February 5, 2026 9:30 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) today outlined its long-term vision to help redefine consumer dermatology standards through the regular use of advanced artificial intelligence technologies designed to make routine skin monitoring as commonplace as fitness and wellness tracking.As consumer health continues to shift toward prevention, personalization, and data-driven insights, MDCE is positioning itself at the intersection of...

Read more

Agape ATP Corporation Receives Nasdaq Delisting Notice

February 5, 2026 9:00 AM

Agape ATP Corporation (NASDAQ:ATPC) ("ATPC" or "the Company") announced that it has received a notification from The Nasdaq Stock Market LLC ("Nasdaq") regarding the potential delisting of its common stock.As previously disclosed on 29 January 2026, the Company received a notification from Nasdaq on 27 January 2026 informing the Company that it was not in compliance with Nasdaq Listing Rule 5550(a)(2), which requires listed securities to...

Read more

Sacred Connection Launches Comprehensive Educational Guide to Traditional Rapé Medicine

February 5, 2026 9:00 AM

Sacred Connection, an ethical supplier of sacred Amazonian plant medicines, is proud to announce the launch of its new educational guide: What Is Rapé?. Inspired by growing global curiosity around the spiritual and ancestral wellness practices of the Brazilian Amazon, the highly accessible guide covers such important topics as traditional rapé usage, its origins, and its cultural significance, and is intended to help bridge the gap between...

Read more

Endomimetics Announces Strategic Restructuring into IP Foundry to Accelerate Bionanomatrix(TM) Clinical Applications

February 5, 2026 9:00 AM

Endomimetics, a leader in biomimetic nanotechnology, today announced the completion of a major corporate restructuring. The company has transitioned to an IP Foundry model, establishing itself as the central intellectual property (IP) owner and research and development engine for its proprietary Bionanomatrix™ technology.Under this new organizational structure, Endomimetics will focus its resources on discovering, de-risking, and packaging...

Read more

Tenon Medical, Inc. Sets Date for Fourth Quarter and Full Year 2025 Earnings, Reaffirms Expected Revenues

February 5, 2026 8:30 AM

Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company redefining care for patients suffering from sacro-pelvic disorders, today announced plans to release financial results for the fourth quarter and full year 2025 ended December 31, 2025 after market close on Thursday, March 19, 2026. The Company will also hold a conference call on the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The...

Read more

VSEE Health Announces Strategic Managed Services Partnership With GoMyRx, an Affiliate of GoMyDocs, to Accelerate Integrated Digital Healthcare Delivery

February 5, 2026 8:30 AM

VSEE Health, Inc. (NASDAQ:VSEE), a provider of AI-enabled telehealth and enterprise virtual care solutions, today announced a strategic managed services partnership with GoMyRx, a digital prescription fulfillment platform and affiliate company of the GoMyDocs healthcare ecosystem, designed to expand integrated digital healthcare delivery capabilities and support telehealth-enabled medication fulfillment nationwide.GoMyRx currently operates a...

Read more

Telomir Pharmaceuticals Reports New Data Supporting an Epigenetic Modulation Mechanism Implicated in Cancer and Aging

February 5, 2026 8:00 AM

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a preclinical-stage biotechnology company developing small-molecule therapeutics targeting fundamental biological mechanisms implicated in cancer, aging, and degenerative disease, today announced new cellular study results demonstrating that Telomir-1, in the form of Telomir-Zn, induces a rapid and coordinated intracellular redistribution of zinc and iron.These findings...

Read more

Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, to Showcase BUZZ BOMB(TM) Caffeine and its Innovative Sublingual Delivery Technology at The Sports & Active Nutrition Summit

February 5, 2026 8:00 AM

Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), wholly owned subsidiary, Buzz Bomb Caffeine Company, a marketer of a proprietary sublingual caffeine supplement today announced its participation at The Sports & Active Nutrition Summit USA, scheduled for February 18-20 in San Diego, CA. Aspire will feature its flagship caffeine product, BUZZ BOMB™, at the event.The Sports & Active Nutrition Summit USA is a premier...

Read more

Zomedica Announces "Fourth Friday at Four" Webinar on February 27th Focused on Research & Development and Its Innovation Pipeline

February 5, 2026 6:30 AM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative diagnostic and therapeutic devices for equine and companion animals, today announced the next installment of its "Fourth Friday at Four" investor webinar series, scheduled for Friday, February 27, 2026 at 4:00 p.m. Eastern Time.The February program, titled "Inside Innovation: Advancing Animal Health Through Research & Development," will...

Read more

BioNxt Secures Innovative Chaperone Technology to Enhance Oral Thin-Film Drug Delivery

February 5, 2026 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, today announced the signing of a non-binding letter of intent ("LOI") outlining a proposed transaction pursuant to which BioNxt would secure exclusive rights to advanced drug chaperone technology for oral dissolvable applications from a third-party biotechnology developer focused on...

Read more